Publikationen 2022
- Fuchs CD, Trauner M.
Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.
Nat Rev Gastroenterol Hepatol. 2022 Feb 14. doi: 10.1038/s41575-021-00566-7. - Scheiner B, Balcar L, Johanna Nussbaumer R, Weinzierl J, Paternostro R, Simbrunner B, Hartl L, Jachs M, Bauer D, Stättermayer AF, Semmler G, Pinter M, Ay C, Quehenberger P, Trauner M, Reiberger T, Lisman T, Mandorfer M.
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
J Hepatol. 2022 Jan 20:S0168-8278(22)00009-5. doi: 10.1016/j.jhep.2021.12.038.
- Burghart L, Halilbasic E, Schwabl P, Simbrunner B, Stättermayer AF, Petrenko O, Scheiner B, Bauer D, Pinter M, Boztug K, Mandorfer M, Trauner M, Reiberger T.
Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.
J Gastroenterol. 2022 Feb;57(2):99-110. doi: 10.1007/s00535-021-01839-3.
- Königshofer P, Hofer BS, Brusilovskaya K, Simbrunner B, Petrenko O, Wöran K, Herac M, Stift J, Lampichler K, Timelthaler G, Bauer D, Hartl L, Robl B, Sibila M, Podesser BK, Oberhuber G, Schwabl P, Mandorfer M, Trauner M, Reiberger T.
Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies.
Hepatology. 2022 Mar;75(3):610-622. doi: 10.1002/hep.32220.
- Scheiner B, Pomej K, Kirstein MM, Hucke F, Finkelmeier F, Waidmann O, Himmelsbach V, Schulze K, von Felden J, Fründt TW, Stadler M, Heinzl H, Shmanko K, Spahn S, Radu P, Siebenhüner AR, Mertens JC, Rahbari NN, Kütting F, Waldschmidt DT, Ebert MP, Teufel A, De Dosso S, Pinato DJ, Pressiani T, Meischl T, Balcar L, Müller C, Mandorfer M, Reiberger T, Trauner M, Personeni N, Rimassa L, Bitzer M, Trojan J, Weinmann A, Wege H, Dufour JF, Peck-Radosavljevic M, Vogel A, Pinter M.
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.
J Hepatol. 2022 Feb;76(2):353-363. doi: 10.1016/j.jhep.2021.09.035.
- Trauner M, Fuchs CD.
Novel therapeutic targets for cholestatic and fatty liver disease.
Gut. 2022 Jan;71(1):194-209. doi: 10.1136/gutjnl-2021-324305 - Fuchs CD, Radun R, Dixon ED, Mlitz V, Timelthaler G, Halilbasic E, Herac M, Jonker JW, Ronda OAHO, Tardelli M, Haemmerle G, Zimmermann R, Scharnagl H, Stojakovic T, Verkade HJ, Trauner M.
Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice.
Hepatology. 2022 Jan;75(1):125-139. doi: 10.1002/hep.32112.